Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC SYNDROME-RELATED DISEASES, COMPRISING, AS ACTIVE INGREDIENT, DENDROPANAX TRIFIDUS SAP EXTRACT OR COMPOUND DERIVED THEREFROM
Document Type and Number:
WIPO Patent Application WO/2023/075489
Kind Code:
A1
Abstract:
The present invention relates to: a pharmaceutical composition for preventing or treating metabolic syndrome-related diseases, comprising, as an active ingredient, a Dendropanax trifidus sap extract or a compound derived therefrom; and the like. The composition, of the present invention, comprising, as an active ingredient, a Dendropanax trifidus sap extract or a compound derived therefrom, has low toxicity, regulates glucose metabolism, and increases glycolysis and mitochondrial respiration so as to increase muscular metabolism, and thus is expected to be effectively used in the prevention or treatment of metabolic syndrome-related diseases including hyperglycemia and obesity.

Inventors:
YANG HYUN-JEONG (KR)
LEE SEUNG HEUN (KR)
Application Number:
PCT/KR2022/016658
Publication Date:
May 04, 2023
Filing Date:
October 28, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV OF BRAIN EDUCATION INDUSTRIAL COOPERATION GROUP (KR)
International Classes:
A61K36/25; A23L33/105; A61K31/015; A61P3/00; A61P9/10; A61P9/12
Foreign References:
KR20170022431A2017-03-02
KR101467407B12014-12-03
KR101434994B12014-09-15
KR20160107679A2016-09-19
KR20000004499A2000-01-25
Other References:
LEE AHREUM, SUGIURA YUKI, CHO IK-HYUN, SETOU NORIKO, KOH EUGENE, SONG GYUN JEE, LEE SEUNGHEUN, YANG HYUN-JEONG: "In Vivo Hypoglycemic Effects, Potential Mechanisms and LC-MS/MS Analysis of Dendropanax Trifidus Sap Extract", NUTRIENTS, vol. 13, no. 12, 30 November 2021 (2021-11-30), pages 4332, XP093062189, DOI: 10.3390/nu13124332
Attorney, Agent or Firm:
LEE, Myoung-Jin (KR)
Download PDF: